[go: up one dir, main page]

DK1560819T3 - Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning - Google Patents

Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning

Info

Publication number
DK1560819T3
DK1560819T3 DK03781830T DK03781830T DK1560819T3 DK 1560819 T3 DK1560819 T3 DK 1560819T3 DK 03781830 T DK03781830 T DK 03781830T DK 03781830 T DK03781830 T DK 03781830T DK 1560819 T3 DK1560819 T3 DK 1560819T3
Authority
DK
Denmark
Prior art keywords
thc
cannabinoid
purification
esters
crystalline
Prior art date
Application number
DK03781830T
Other languages
Danish (da)
English (en)
Inventor
John R Duchek
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DK1560819T3 publication Critical patent/DK1560819T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK03781830T 2002-11-12 2003-11-06 Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning DK1560819T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20
PCT/US2003/035599 WO2004043946A1 (fr) 2002-11-12 2003-11-06 Derives cristallins d'un cannabinoide et procede de purification d'un cannabinoide

Publications (1)

Publication Number Publication Date
DK1560819T3 true DK1560819T3 (da) 2009-02-09

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03781830T DK1560819T3 (da) 2002-11-12 2003-11-06 Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning

Country Status (13)

Country Link
US (1) US7402686B2 (fr)
EP (1) EP1560819B1 (fr)
JP (1) JP2006508132A (fr)
AT (1) ATE410419T1 (fr)
AU (1) AU2003287585B2 (fr)
CA (1) CA2504743C (fr)
DE (1) DE60324011D1 (fr)
DK (1) DK1560819T3 (fr)
ES (1) ES2315548T3 (fr)
MX (1) MXPA05004966A (fr)
PT (1) PT1560819E (fr)
SI (1) SI1560819T1 (fr)
WO (1) WO2004043946A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (fr) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Composition pour dissolution rapid d'un composè lipophile
WO2006007734A1 (fr) * 2004-07-19 2006-01-26 Cilag Ltd. Procede de fabrication de tetrahydrocannabinol pur
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
EP2578577A1 (fr) * 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Esters sulfonyles de tétrahydrocannabinol et ses dérivés
CA2659775A1 (fr) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Formulations aqueuses de dronabinol
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
CA2698752A1 (fr) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Formulations liquides a usage oral de cannabinoides et procedes de traitement avec celles-ci
WO2009099868A1 (fr) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Procédé pour la préparation du (-)-delta 9-tétrahydrocannabinol
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
EP3745884A1 (fr) 2018-01-31 2020-12-09 Canopy Holdings, Llc Poudre de chanvre
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
WO2021055079A1 (fr) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Système d'administration de médicament avec substrats empilables
JP2023512578A (ja) * 2020-02-06 2023-03-27 ロンドン ファーマシューティカルズ アンド リサーチ コーポレーション Cアナビンオイド硫酸エステル、その塩及び用途
AU2022362107A1 (en) * 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
WO2006000734A1 (fr) 2004-06-23 2006-01-05 Bp P.L.C. Synthese de gel de silice micro-poreux et son application pour la preparation de catalyseurs servant a la synthese de composes oxygenes en c2 a partir d'un gaz de synthese

Also Published As

Publication number Publication date
AU2003287585A1 (en) 2004-06-03
EP1560819B1 (fr) 2008-10-08
EP1560819A1 (fr) 2005-08-10
PT1560819E (pt) 2008-11-03
WO2004043946A1 (fr) 2004-05-27
ES2315548T3 (es) 2009-04-01
SI1560819T1 (sl) 2009-06-30
JP2006508132A (ja) 2006-03-09
US7402686B2 (en) 2008-07-22
ATE410419T1 (de) 2008-10-15
AU2003287585B2 (en) 2009-05-07
US20060094774A1 (en) 2006-05-04
CA2504743A1 (fr) 2004-05-27
DE60324011D1 (de) 2008-11-20
CA2504743C (fr) 2012-04-24
MXPA05004966A (es) 2005-08-02

Similar Documents

Publication Publication Date Title
DK1560819T3 (da) Krystallinske cannabinoidderivater og fremgangsmåde til cannabinoidrensning
CY1112347T1 (el) Διεργασια για την κρυσταλλωση της (r)- ή της (s)-λανσοπραζολης
DE60330732D1 (de) Wahrscheinlichkeitsschätzung zur klassifikation mittels des K nächsten Nachbarn
DE60322656D1 (de) Gerät zur Berechnung von Druck/Temperatur
NO20061396L (no) Nye heterocykliske forbindelser som HSP90-inhibitorer
NO20051726L (no) Pyrimidinonderivaer som terapeutiske midler ovenfor akutte og kroniske inflammasjons-, iskemiske og remodeleringsprosesser
NZ592897A (en) Crystals of laquinimod sodium, and process for the manufacture thereof
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
DE50200260D1 (de) Klimatisierungssystem
BRPI0510260A (pt) método para purificar um composto, e, kit farmacêutico
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
MY143958A (en) Quinazolinone derivatives and their use as cb agonists
BRPI0400375A (pt) Processo para remover vìrus em soluções de fibrinogênio para aplicação terapêutica e fibrinogênio obtido pelo dito processo
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
MXPA04006803A (es) Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma.
ATE397620T1 (de) Aufreinigungsverfahren, das eine mikrofiltration bei erhöhten temperaturen beinhaltet
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EP1460997A4 (fr) Procedes de purification de levofloxacine
IS7808A (is) Aðferð til nýmyndunar í iðnaði á metýldíester 5-amínó-3-karboxýmetýl-4-sýanó-2-þíófenkarboxýlsýru
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
ATE382039T1 (de) Benzimidazolone und ihre verwendung als cytokininhibitoren
PL377232A1 (pl) Nowy proces syntezy kwasu (2S, 3aS, 7aS)-perhydroindolo-2- karboksylowego i jego estrów oraz zastosowanie w syntezie perindoprylu
IS7477A (is) Aðferð við framleiðslu sýrusalts af gemifloxasíni
NO20055181D0 (no) Krystall av benzimidazolderivat og fremgangsmate for fremstilling av samme